Position in JNJ
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$2,101,601
+$85,949 QoQ
Shares Held
8,275
+0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
#2,304
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 77%
Shared 0%
None 23%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Enterprise Financial Services Corp holds $12,653,618 across 10 Drug Manufacturers - General names. JNJ ranks #4 (16.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
13,105 | $3,297,741 | |
| 2 | LLY |
ELI LILLY & Co
|
2,069 | $2,481,620 | |
| 3 | MRK |
Merck & Co., Inc.
|
18,619 | $2,392,541 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
8,275 | $2,101,601 | |
| 5 | PFE |
Pfizer Inc
|
24,377 | $586,998 | |
| 6 | AMGN |
Amgen Inc
|
1,281 | $463,875 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
7,683 | $442,694 | |
| 8 | NVS |
Novartis AG
|
2,081 | $326,133 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,101,601 | 8,275 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $2,015,652 | 8,246 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,808,535 | 8,739 | Shares | Defined | 2026-01-14 | |
| 2025-09-30 | $1,609,074 | 8,678 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $1,348,323 | 8,827 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,341,479 | 8,089 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,327,321 | 9,178 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $1,395,660 | 8,612 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,295,415 | 8,863 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,603,887 | 10,139 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,748,904 | 11,158 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,845,481 | 11,849 | Shares | Defined | 2023-10-31 | |
| 2023-06-30 | $2,227,899 | 13,460 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,125,050 | 13,710 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,513,552 | 14,229 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,560,831 | 15,676 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,119,915 | 17,576 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $3,143,705 | 17,738 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,904,330 | 22,823 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,368,752 | 39,435 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $2,967,625 | 18,014 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $2,825,340 | 17,191 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $2,688,363 | 17,082 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $2,674,777 | 17,966 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,070,936 | 21,837 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $3,021,365 | 23,041 | Shares | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||